Yulin Wanga, Jing Liua, Zhongmin Zhangb, Xiaoli Wangc, Chaodong Zhanga,1
aDepartment of Neurology, The first affiliated hospital, China Medical University, Shen Yang, China
bDepartment of Neurology, Hong Qi Hospital, Mu Dan Jiang Medical College, Mu Dan Jiang, China
cDepartment of Aging diseases, The second affiliated hospital, Mu Dan Jiang Medical College, Mu Dan Jiang, China
AbstractThe present work explored the bloodbrain barrier (BBB) changes in a mice model of Alzheimers
disease (AD) (APP/PS1 double mutant). The transgenic mice model showed overexpression of A
1-42 in the
brain and the loss of learning functions. The test with tail vein injection of Evans Blue (EB) showed more EB
fluorescence in the brain tissue, suggesting an increased BBB permeability. Additionally, Electronic micro-
scope (EM) images showed changes in base membrane, vessel-associated glial cells, pericytes, and endothelial
cells. This work supported the BBB dysfunction hypothesis in AD, and suggested that APP/PS1 mice could be
a suitable model in testing BBB-crossing drugs of AD.
Keywords: Alzheimers disease; bloodbrain barrier; electronic microscopy; Evans blue; APP/PS1; transgenic
DOI: 10.1134/S1819712411030135
Pleiades Publishing home page | journal home page | top
If you have any problems with this server, contact webmaster.